Order Article Reprints

Diekstra MHM, Swen JJ, van der Zanden LFM, Vermeulen SH, Boven E, Mathijssen RHJ, Fukunaga K, Mushiroda T, Hongo F, Oosterwijk E, et al. Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib. Cancers. 2022; 14(12):2838. https://doi.org/10.3390/cancers14122838

Diekstra, Meta H. M., Jesse J. Swen, Loes F. M. van der Zanden, Sita H. Vermeulen, Epie Boven, Ron H. J. Mathijssen, Koya Fukunaga, Taisei Mushiroda, Fumiya Hongo, Egbert Oosterwijk, and et al. 2022. "Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib" Cancers 14, no. 12: 2838. https://doi.org/10.3390/cancers14122838

Diekstra, M. H. M., Swen, J. J., van der Zanden, L. F. M., Vermeulen, S. H., Boven, E., Mathijssen, R. H. J., Fukunaga, K., Mushiroda, T., Hongo, F., Oosterwijk, E., Cambon-Thomsen, A., Castellano, D., Fritsch, A., Donas, J. G., Rodriguez-Antona, C., Ruijtenbeek, R., Radu, M. T., Eisen, T., Junker, K., ... Guchelaar, H.-J. (2022). Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib. Cancers, 14(12), 2838. https://doi.org/10.3390/cancers14122838